Here are the top 5 articles for the month of October.
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of October.
Number 5: A study assessing adherence to National Comprehensive Cancer Network guidelines in the neoadjuvant treatment of breast cancer concluded that adherence to the guidelines leads to improved outcomes.
Number 4: A phase 3 trial has found that some patients with hard-to-treat leukemia and lymphoma showed significant improvement and longer progression-free survival with duvelisib
Number 3: Drs James P Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Physiology or Medicine for their research showing the potential of immune checkpoint inhibitors in cancer.
Number 2: During a session at the National Association of ACOs Fall 2018 conference, panelists discussed how accountable care organizations can design and implement new strategies that deliver high-quality, low-cost care for patients with complex, chronic conditions.
Number 1: A new law signed by California Governor Jerry Brown will put new requirements on pharmacy benefit managers in the state, including barring so-called gag clauses that prevented pharmacists from telling consumers when they would save money by paying cash for a prescription instead of getting it through insurance.
To read all of these articles and more, visit AJMC.com
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More